The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Fexofenadine Market Research Report 2025
Synopsis
Fexofenadine is an allergic symptom in a drug against an antihistamine, such as for the treatment of hay fever and urticaria. Treatment, fexofenadine is a selective peripheral H1 receptor blocker
The global Fexofenadine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Fexofenadine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fexofenadine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Fexofenadine include Viruj Pharma, Cemex Pharma, Smaart Pharmaceutticals, Titan Pharma, AFCL, Synkromax, Farmhispania, Gen Pharma and Admiron Life Sciences Private Limited, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Fexofenadine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fexofenadine.
Report Scope
The Fexofenadine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fexofenadine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fexofenadine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Viruj Pharma
Cemex Pharma
Smaart Pharmaceutticals
Titan Pharma
AFCL
Synkromax
Farmhispania
Gen Pharma
Admiron Life Sciences Private Limited
JRC
Archerchem
Sibram
Sumitomo Chemical
Panchsheel
CAMEO HEALTH CARE
CEPiA-Sanofi
Va Sudha Pharma Chem Limited
VPL Chemicals
Zhejiang Excel Pharmaceutical
Segment by Type
Purity:98%
Purity:Above 98%
Segment by Application
Hay Fever Treatment
Urticaria Treatment
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fexofenadine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fexofenadine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Fexofenadine is an allergic symptom in a drug against an antihistamine, such as for the treatment of hay fever and urticaria. Treatment, fexofenadine is a selective peripheral H1 receptor blocker
The global Fexofenadine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Fexofenadine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fexofenadine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Fexofenadine include Viruj Pharma, Cemex Pharma, Smaart Pharmaceutticals, Titan Pharma, AFCL, Synkromax, Farmhispania, Gen Pharma and Admiron Life Sciences Private Limited, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Fexofenadine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fexofenadine.
Report Scope
The Fexofenadine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fexofenadine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fexofenadine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Viruj Pharma
Cemex Pharma
Smaart Pharmaceutticals
Titan Pharma
AFCL
Synkromax
Farmhispania
Gen Pharma
Admiron Life Sciences Private Limited
JRC
Archerchem
Sibram
Sumitomo Chemical
Panchsheel
CAMEO HEALTH CARE
CEPiA-Sanofi
Va Sudha Pharma Chem Limited
VPL Chemicals
Zhejiang Excel Pharmaceutical
Segment by Type
Purity:98%
Purity:Above 98%
Segment by Application
Hay Fever Treatment
Urticaria Treatment
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fexofenadine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fexofenadine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Fexofenadine Market Overview
1.1 Product Overview and Scope of Fexofenadine
1.2 Fexofenadine Segment by Type
1.2.1 Global Fexofenadine Market Value Comparison by Type (2024-2030)
1.2.2 Purity:98%
1.2.3 Purity:Above 98%
1.3 Fexofenadine Segment by Application
1.3.1 Global Fexofenadine Market Value by Application: (2024-2030)
1.3.2 Hay Fever Treatment
1.3.3 Urticaria Treatment
1.4 Global Fexofenadine Market Size Estimates and Forecasts
1.4.1 Global Fexofenadine Revenue 2019-2030
1.4.2 Global Fexofenadine Sales 2019-2030
1.4.3 Global Fexofenadine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Fexofenadine Market Competition by Manufacturers
2.1 Global Fexofenadine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Fexofenadine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Fexofenadine Average Price by Manufacturers (2019-2024)
2.4 Global Fexofenadine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fexofenadine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fexofenadine, Product Type & Application
2.7 Fexofenadine Market Competitive Situation and Trends
2.7.1 Fexofenadine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fexofenadine Players Market Share by Revenue
2.7.3 Global Fexofenadine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fexofenadine Retrospective Market Scenario by Region
3.1 Global Fexofenadine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Fexofenadine Global Fexofenadine Sales by Region: 2019-2030
3.2.1 Global Fexofenadine Sales by Region: 2019-2024
3.2.2 Global Fexofenadine Sales by Region: 2025-2030
3.3 Global Fexofenadine Global Fexofenadine Revenue by Region: 2019-2030
3.3.1 Global Fexofenadine Revenue by Region: 2019-2024
3.3.2 Global Fexofenadine Revenue by Region: 2025-2030
3.4 North America Fexofenadine Market Facts & Figures by Country
3.4.1 North America Fexofenadine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Fexofenadine Sales by Country (2019-2030)
3.4.3 North America Fexofenadine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Fexofenadine Market Facts & Figures by Country
3.5.1 Europe Fexofenadine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Fexofenadine Sales by Country (2019-2030)
3.5.3 Europe Fexofenadine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fexofenadine Market Facts & Figures by Country
3.6.1 Asia Pacific Fexofenadine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Fexofenadine Sales by Country (2019-2030)
3.6.3 Asia Pacific Fexofenadine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Fexofenadine Market Facts & Figures by Country
3.7.1 Latin America Fexofenadine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Fexofenadine Sales by Country (2019-2030)
3.7.3 Latin America Fexofenadine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fexofenadine Market Facts & Figures by Country
3.8.1 Middle East and Africa Fexofenadine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Fexofenadine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Fexofenadine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fexofenadine Sales by Type (2019-2030)
4.1.1 Global Fexofenadine Sales by Type (2019-2024)
4.1.2 Global Fexofenadine Sales by Type (2025-2030)
4.1.3 Global Fexofenadine Sales Market Share by Type (2019-2030)
4.2 Global Fexofenadine Revenue by Type (2019-2030)
4.2.1 Global Fexofenadine Revenue by Type (2019-2024)
4.2.2 Global Fexofenadine Revenue by Type (2025-2030)
4.2.3 Global Fexofenadine Revenue Market Share by Type (2019-2030)
4.3 Global Fexofenadine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Fexofenadine Sales by Application (2019-2030)
5.1.1 Global Fexofenadine Sales by Application (2019-2024)
5.1.2 Global Fexofenadine Sales by Application (2025-2030)
5.1.3 Global Fexofenadine Sales Market Share by Application (2019-2030)
5.2 Global Fexofenadine Revenue by Application (2019-2030)
5.2.1 Global Fexofenadine Revenue by Application (2019-2024)
5.2.2 Global Fexofenadine Revenue by Application (2025-2030)
5.2.3 Global Fexofenadine Revenue Market Share by Application (2019-2030)
5.3 Global Fexofenadine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Viruj Pharma
6.1.1 Viruj Pharma Corporation Information
6.1.2 Viruj Pharma Description and Business Overview
6.1.3 Viruj Pharma Fexofenadine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Viruj Pharma Fexofenadine Product Portfolio
6.1.5 Viruj Pharma Recent Developments/Updates
6.2 Cemex Pharma
6.2.1 Cemex Pharma Corporation Information
6.2.2 Cemex Pharma Description and Business Overview
6.2.3 Cemex Pharma Fexofenadine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Cemex Pharma Fexofenadine Product Portfolio
6.2.5 Cemex Pharma Recent Developments/Updates
6.3 Smaart Pharmaceutticals
6.3.1 Smaart Pharmaceutticals Corporation Information
6.3.2 Smaart Pharmaceutticals Description and Business Overview
6.3.3 Smaart Pharmaceutticals Fexofenadine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Smaart Pharmaceutticals Fexofenadine Product Portfolio
6.3.5 Smaart Pharmaceutticals Recent Developments/Updates
6.4 Titan Pharma
6.4.1 Titan Pharma Corporation Information
6.4.2 Titan Pharma Description and Business Overview
6.4.3 Titan Pharma Fexofenadine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Titan Pharma Fexofenadine Product Portfolio
6.4.5 Titan Pharma Recent Developments/Updates
6.5 AFCL
6.5.1 AFCL Corporation Information
6.5.2 AFCL Description and Business Overview
6.5.3 AFCL Fexofenadine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AFCL Fexofenadine Product Portfolio
6.5.5 AFCL Recent Developments/Updates
6.6 Synkromax
6.6.1 Synkromax Corporation Information
6.6.2 Synkromax Description and Business Overview
6.6.3 Synkromax Fexofenadine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Synkromax Fexofenadine Product Portfolio
6.6.5 Synkromax Recent Developments/Updates
6.7 Farmhispania
6.6.1 Farmhispania Corporation Information
6.6.2 Farmhispania Description and Business Overview
6.6.3 Farmhispania Fexofenadine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Farmhispania Fexofenadine Product Portfolio
6.7.5 Farmhispania Recent Developments/Updates
6.8 Gen Pharma
6.8.1 Gen Pharma Corporation Information
6.8.2 Gen Pharma Description and Business Overview
6.8.3 Gen Pharma Fexofenadine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Gen Pharma Fexofenadine Product Portfolio
6.8.5 Gen Pharma Recent Developments/Updates
6.9 Admiron Life Sciences Private Limited
6.9.1 Admiron Life Sciences Private Limited Corporation Information
6.9.2 Admiron Life Sciences Private Limited Description and Business Overview
6.9.3 Admiron Life Sciences Private Limited Fexofenadine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Admiron Life Sciences Private Limited Fexofenadine Product Portfolio
6.9.5 Admiron Life Sciences Private Limited Recent Developments/Updates
6.10 JRC
6.10.1 JRC Corporation Information
6.10.2 JRC Description and Business Overview
6.10.3 JRC Fexofenadine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 JRC Fexofenadine Product Portfolio
6.10.5 JRC Recent Developments/Updates
6.11 Archerchem
6.11.1 Archerchem Corporation Information
6.11.2 Archerchem Fexofenadine Description and Business Overview
6.11.3 Archerchem Fexofenadine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Archerchem Fexofenadine Product Portfolio
6.11.5 Archerchem Recent Developments/Updates
6.12 Sibram
6.12.1 Sibram Corporation Information
6.12.2 Sibram Fexofenadine Description and Business Overview
6.12.3 Sibram Fexofenadine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sibram Fexofenadine Product Portfolio
6.12.5 Sibram Recent Developments/Updates
6.13 Sumitomo Chemical
6.13.1 Sumitomo Chemical Corporation Information
6.13.2 Sumitomo Chemical Fexofenadine Description and Business Overview
6.13.3 Sumitomo Chemical Fexofenadine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Sumitomo Chemical Fexofenadine Product Portfolio
6.13.5 Sumitomo Chemical Recent Developments/Updates
6.14 Panchsheel
6.14.1 Panchsheel Corporation Information
6.14.2 Panchsheel Fexofenadine Description and Business Overview
6.14.3 Panchsheel Fexofenadine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Panchsheel Fexofenadine Product Portfolio
6.14.5 Panchsheel Recent Developments/Updates
6.15 CAMEO HEALTH CARE
6.15.1 CAMEO HEALTH CARE Corporation Information
6.15.2 CAMEO HEALTH CARE Fexofenadine Description and Business Overview
6.15.3 CAMEO HEALTH CARE Fexofenadine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 CAMEO HEALTH CARE Fexofenadine Product Portfolio
6.15.5 CAMEO HEALTH CARE Recent Developments/Updates
6.16 CEPiA-Sanofi
6.16.1 CEPiA-Sanofi Corporation Information
6.16.2 CEPiA-Sanofi Fexofenadine Description and Business Overview
6.16.3 CEPiA-Sanofi Fexofenadine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 CEPiA-Sanofi Fexofenadine Product Portfolio
6.16.5 CEPiA-Sanofi Recent Developments/Updates
6.17 Va Sudha Pharma Chem Limited
6.17.1 Va Sudha Pharma Chem Limited Corporation Information
6.17.2 Va Sudha Pharma Chem Limited Fexofenadine Description and Business Overview
6.17.3 Va Sudha Pharma Chem Limited Fexofenadine Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Va Sudha Pharma Chem Limited Fexofenadine Product Portfolio
6.17.5 Va Sudha Pharma Chem Limited Recent Developments/Updates
6.18 VPL Chemicals
6.18.1 VPL Chemicals Corporation Information
6.18.2 VPL Chemicals Fexofenadine Description and Business Overview
6.18.3 VPL Chemicals Fexofenadine Sales, Revenue and Gross Margin (2019-2024)
6.18.4 VPL Chemicals Fexofenadine Product Portfolio
6.18.5 VPL Chemicals Recent Developments/Updates
6.19 Zhejiang Excel Pharmaceutical
6.19.1 Zhejiang Excel Pharmaceutical Corporation Information
6.19.2 Zhejiang Excel Pharmaceutical Fexofenadine Description and Business Overview
6.19.3 Zhejiang Excel Pharmaceutical Fexofenadine Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Zhejiang Excel Pharmaceutical Fexofenadine Product Portfolio
6.19.5 Zhejiang Excel Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fexofenadine Industry Chain Analysis
7.2 Fexofenadine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fexofenadine Production Mode & Process
7.4 Fexofenadine Sales and Marketing
7.4.1 Fexofenadine Sales Channels
7.4.2 Fexofenadine Distributors
7.5 Fexofenadine Customers
8 Fexofenadine Market Dynamics
8.1 Fexofenadine Industry Trends
8.2 Fexofenadine Market Drivers
8.3 Fexofenadine Market Challenges
8.4 Fexofenadine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
